Increased frequency of cluster of differentiation 14 (CD14+) monocytes expressing interleukin 1 beta (IL-1β) in Alzheimer's disease patients and intermediate levels in late-onset depression patients

International Journal of Geriatric Psychiatry

Volumn 29, Issue 2, 2014, Pages 137-143

  Torres, Karen Cecília ^a   Lima, Giselle Sabrina ^a   Fiamoncini, Carolina MacIel ^a   Rezende, Vitor Bortolo ^a   Pereira, Patrícia Araújo ^a   Bicalho, Maria Aparecida ^a   Moraes, Edgar Nunes ^a   Romano Silva, Marco Aurélio ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Alzheimer disease; IL 1beta; late onset depression

Indexed keywords

CD14 ANTIGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DEPRESSION; FEMALE; FLOW CYTOMETRY; GERIATRIC DEPRESSION SCALE; HUMAN; HUMAN CELL; LATE ONSET DEPRESSION; MALE; MINI MENTAL STATE EXAMINATION; MONOCYTE; NEUROLOGIC EXAMINATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRODROMAL SYMPTOM; PROTEIN EXPRESSION; VERY ELDERLY;

ALZHEIMER DISEASE; IL-1BETA; LATE -ONSET DEPRESSION;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIGENS, CD14; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; DEPRESSIVE DISORDER; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; MONOCYTES;

EID: 84892441049     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.3973     Document Type: Article

References (31)

1. Alexopoulos GS,. 2005. Depression in the elderly. Lancet 365: 1961-1970. (Pubitemid 40797508)
2. DSM-IV- TR. Diagnostic and Statistical Manual of Mental Disorders. 1994. American Psychiatry Association.
3. Amorim, P,. 2000. MINI International Neuropsychiatric Interview (MINI): validation of a short structured diagnostic psychiatric interview. Rev Bras Psiquiatr 22 (3): 106-115.
4. Britschgi M, Wyss-Coray T,. 2007. Systemic and acquired immune responses in Alzheimer's disease. Review. Int Rev Neurobiol 82: 205-233.
5. Brommelhoff JA, Gatz M, Johansson B, et al,. 2009. Depression as a risk factor or prodromal feature for dementia? Findings in a population-based sample of swedish twins. Psychol Aging 24 (2): 373-384.
6. Cummings JL, Mega M, Gray K, et al,. 1994. Neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44 (12): 2308-2323.
7. Diniz BS, Teixeira AL, Talib L, Gattaz WF, Forlenza OV,. 2010. Interleukin-1beta serum levels is increased in antidepressant-free elderly depressed patients. Am J Geriatr Psychiatry 18 (2): 172-176.
8. D'Mello C, Le T, Swain MG,. 2009. Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation. J Neurosci 29 (7): 2089-2102.
9. Folstein MF, Folstein SE, McHugh PR,. 1975. "Mini-mental state". A practical method for grading the cognitive status of patients for the clinician. J Psychiatr Rev 12 (3): 189-195.
10. Forlenza OV, Diniz BS, Talib LL, et al,. 2009. Increased serum IL-1beta level in Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord 28 (6): 507-512.
11. Jorm AF,. 2001. History of depression as a risk factor for dementia: an updated review. Aust N Z J Psychiatry 35: 776-781. (Pubitemid 34048449)
12. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW,. 1963. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 185: 914-919.
13. Kim SM, Song J, Kim S, et al,. 2011. Identification of peripheral inflammatory markers between normal control and Alzheimer's disease. BMC Neurol 12: 11:51.
14. Maes M, Yirmyia R, Noraberg J, et al,. 2009. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis 24: 27-53.
15. Matousek SB, Ghosh S, Shaftel SS, et al,. 2012. Chronic IL-1β-mediated neuroinflammation mitigates amyloid pathology in a mouse model of Alzheimer's disease without inducing overt neurodegeneration. J Neuroimmune Pharmacol 7 (1): 156-64. Epub 2011 Dec 16.
16. McKhann G, Drachman D, Folstein M, et al,. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34 (7): 939-944. (Pubitemid 14076461)
17. Morris JC,. 1993. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43 (11): 2412-2414. (Pubitemid 23346995)
18. Morris JC, Mohs RC, Hughes JP, et al,. 1989. The consortium to establish a registry for Alzheimer's disease. Neurology 39 (9): 1159-1165.
19. Ohanna I, Golander H, Barak Y,. 2011. Does late onset depression predispose to dementia? A retrospective, case-controlled study. Compr Psychiatry 52 (6): 659-661.
20. Paludan SR,. 2000. Synergistic action of pro-inflammatory agents: cellular and molecular aspects. J Leukoc Biol 67 (1): 18-25. (Pubitemid 30046813)
21. Pfeffer RI, Kurosaki TT, Harrah CH Jr, Chance JM, Filos S,. 1982. Measurement of functional activities on older adults in the community. J Gerontol 37 (3): 323-329. (Pubitemid 12117513)
22. Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A,. 1980. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 7 (5): 486-488. (Pubitemid 10073130)
23. Sheikh JL, Yesavage JA,. 1986. Geriatric depression scale (GDS): recent evidence and development of a shorter version. In: BRINK TL. Clinical gerontology: guide to assessment and intervention. Haworth, New York; 163-173.
24. Smith RS,. 1991. The macrophage theory of depression. Med Hypotheses 35 (4): 298-306.
25. Tan ZS, Beiser AS, Vasan RS, et al,. 2007. Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology 68 (22): 1902-1908. (Pubitemid 46848622)
26. Thomas AJ, Davis S, Morris C, et al,. 2005. Increase in interleukin-1beta in late-life depression. Am J Psychiatry 162 (1): 175-177.
27. Torres KC, Souza BR, Miranda DM, et al,. 2009. Expression of neuronal calcium sensor-1 (NCS-1) is decreased in leukocytes of schizophrenia and bipolar disorder patients. Prog Neuropsychopharmacol Biol Psychiatry 33 (2): 229-234.
28. Vilalta-Franch J, Lõpez-Pousa S, Llinàs-Reglà J, et al,. 2012. Depression subtypes and 5-year risk of dementia and Alzheimer disease in patients aged 70 years. Int J Geriatr Psychiatry. 28(4):341-350.
29. Wang L, Potter GG, Krishnan RK, et al,. 2012. Neural correlates associated with cognitive decline in late-life depression. Am J Geriatr Psychiatry 20 (8): 653-63.
30. Wyss-Coray T,. 2006. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Review. Nat Med 12 (9): 1005-1015. (Pubitemid 44353380)
31. Zunszain PA, Hepgul N, Pariante CM,. 2012. Inflammation and depression. Curr Top Behav Neurosci 2012: 3.